GPR35 inhibitor therapy(ThirtyFiveBio)

N/A

Report date: 2023/11/10 17:48:08

Base Information

Drug NameGPR35 inhibitor therapy(ThirtyFiveBio)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor 35 inhibitors
TargetsG-protein coupled receptor 35
Therapy Area/IndicationsInflammationGastrointestinal DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThirtyFiveBio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesThirtyFiveBio Ltd
Inactive CompaniesN/A
Active IndicationsInflammationGastrointestinal DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A